Alto Neuroscience, Inc.
ANROHealthcare|Biotechnology|US
$25.16
+3.29 (+15.04%)
DCF Value
$5.91
Tangible Book / Share
$5.12
Cash / Share
$5.69
Ownership Breakdown
90.6%
Float
39.2M
Shares Outstanding
35.6M
Float Shares
Major Holders (30)
Combined: 159.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | Investment adviser | 9.99% | 4,176,711 | Aug 14, 2026 | 13D/G |
| Joseph Edelman | Individual | 9.99% | 4,176,711 | Aug 14, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 9.99% | 4,176,711 | Aug 14, 2026 | 13D/G |
| Commodore Capital LP | IA, PN | 9.90% | 3,588,180 | May 15, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 9.90% | 3,588,180 | May 15, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 9.90% | 3,588,180 | May 15, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 9.90% | 3,588,180 | May 15, 2026 | 13D/G |
| Sirenia Capital Management LP | IA, PN | 6.20% | 2,219,568 | Aug 14, 2026 | 13D/G |
| Alex Silverstein | HC, IN | 6.20% | 2,219,568 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.00% | 2,104,406 | Jul 27, 2026 | 13D/G |
| EcoR1 Capital, LLC | IA, OO | 5.80% | 2,232,000 | Jul 20, 2026 | 13D/G |
| Oleg Nodelman | HC, IN | 5.80% | 2,232,000 | Jul 20, 2026 | 13D/G |
| Amit Etkin | Individual | 5.40% | 1,461,130 | Nov 14, 2024 | 13D/G |
| EcoR1 Capital Fund Qualified, L.P. | Partnership | 5.30% | 2,065,935 | Jul 20, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 5.02% | 1,970,108 | Oct 30, 2026 | 13D/G |
| Steven Boyd | HC, IN | 4.94% | 1,536,000 | Feb 18, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.94% | 1,536,000 | Feb 18, 2026 | 13D/G |
| FMR LLC | Holding company | 4.70% | 1,265,546 | Feb 12, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 4.70% | 1,265,546 | Feb 12, 2025 | 13D/G |
| Steven A. Cohen | Individual | 3.70% | 1,170,865 | May 15, 2026 | 13D/G |
| Anup Arora | HC, IN | 2.40% | 788,995 | Feb 17, 2026 | 13D/G |
| Parag Shah | HC, IN | 2.40% | 788,995 | Feb 17, 2026 | 13D/G |
| K2 HealthVentures Equity Trust LLC | Other | 2.40% | 788,995 | Feb 17, 2026 | 13D/G |
| Vestal Point Capital, LP | IA, PN | 2.20% | 785,000 | Aug 14, 2026 | 13D/G |
| Ryan Wilder | HC, IN | 2.20% | 785,000 | Aug 14, 2026 | 13D/G |
| Point72 Biotech Private Investments, LLC | Other | 2.10% | 667,778 | May 15, 2026 | 13D/G |
| Differentiated Ventures Investments, LLC | Other | 2.10% | 667,778 | May 15, 2026 | 13D/G |
| 72 Investment Holdings, LLC | Other | 2.10% | 667,778 | May 15, 2026 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 1.60% | 503,087 | May 15, 2026 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 1.60% | 503,087 | May 15, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,906,812 acquired · 2,486,530 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Smith Nicholas Conrad | PRESIDENT AND CFO | Oct 2, 2026 | OPTION EX. | 55,000 | $2.32 | $127.6K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Oct 2, 2026 | OPTION EX. | 55,000 | $2.32 | $127.6K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 29, 2026 | OPTION EX. | 56,455 | $2.35 | $132.7K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 29, 2026 | OPTION EX. | 54,375 | $2.35 | $127.8K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 30, 2026 | OPTION EX. | 24,056 | $2.35 | $56.5K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 29, 2026 | OPTION EX. | 56,455 | $2.35 | $132.7K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 30, 2026 | OPTION EX. | 24,056 | $2.35 | $56.5K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 29, 2026 | OPTION EX. | 54,375 | $2.35 | $127.8K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 30, 2026 | SELL | 23,170 | $25.78 | $597.3K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 30, 2026 | SELL | 886 | $26.87 | $23.8K | Form 4 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | Sep 29, 2026 | SELL | 110,830 | $26.58 | $2.9M | Form 4 |
| Miller Andrew Craig | director | May 27, 2026 | AWARD | 26,000 | $20.44 | $531.4K | Form 4 |
| Miller Andrew Craig | director: | May 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | May 14, 2026 | GIFT | 400,000 | — | — | Form 4 |
| Sanchez Ramiro | director | May 12, 2026 | AWARD | 10,958 | $24.63 | $269.9K | Form 4 |
| Cox Christopher Nixon | director | May 12, 2026 | AWARD | 10,958 | $24.63 | $269.9K | Form 4 |
| Manji Husseini | director | May 12, 2026 | AWARD | 10,958 | $24.63 | $269.9K | Form 4 |
| Dreyfus Andrew | director | May 12, 2026 | AWARD | 10,958 | $24.63 | $269.9K | Form 4 |
| York Gwill | director | May 12, 2026 | AWARD | 10,958 | $24.63 | $269.9K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Mar 1, 2026 | TAX W/H | 6,227 | $19.69 | $122.6K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Mar 1, 2026 | TAX W/H | 2,806 | $19.69 | $55.3K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Feb 11, 2026 | AWARD | 306,000 | $16.71 | $5.1M | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Feb 11, 2026 | AWARD | 124,000 | $16.71 | $2.1M | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Feb 11, 2026 | AWARD | 200,000 | $16.71 | $3.3M | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Feb 11, 2026 | AWARD | 131,000 | $16.71 | $2.2M | Form 4 |
| York Gwill | director | Jan 2, 2026 | AWARD | 5,243 | $16.59 | $87.0K | Form 4 |
| Cox Christopher Nixon | director | Jan 2, 2026 | AWARD | 7,189 | $16.59 | $119.3K | Form 4 |
| Manji Husseini | director | Jan 2, 2026 | AWARD | 4,228 | $16.59 | $70.1K | Form 4 |
| Sanchez Ramiro | director | Jan 2, 2026 | AWARD | 3,806 | $16.59 | $63.1K | Form 4 |
| Sanchez Ramiro | director | Aug 12, 2025 | AWARD | 30,574 | $3.18 | $97.2K | Form 4 |
| Sanchez Ramiro | director | Aug 12, 2025 | AWARD | 3,928 | $3.18 | $12.5K | Form 4 |
| Sanchez Ramiro | director: | Aug 12, 2025 | OTHER | 0 | — | — | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | AWARD | 188,000 | $2.35 | $441.8K | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | AWARD | 125,000 | $2.35 | $293.8K | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | AWARD | 8,000 | $2.35 | $18.8K | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | DISPOSED | 188,000 | $12.40 | $2.3M | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | DISPOSED | 125,000 | $4.20 | $525.0K | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Jul 3, 2025 | DISPOSED | 8,000 | $14.88 | $119.0K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | AWARD | 123,645 | $2.35 | $290.6K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | AWARD | 76,000 | $2.35 | $178.6K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | AWARD | 73,000 | $2.35 | $171.6K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | AWARD | 33,008 | $2.35 | $77.6K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | AWARD | 22,481 | $2.35 | $52.8K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | DISPOSED | 123,645 | $5.30 | $655.3K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | DISPOSED | 33,008 | $6.23 | $205.6K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | DISPOSED | 73,000 | $14.88 | $1.1M | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 3, 2025 | DISPOSED | 76,000 | $4.20 | $319.2K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | AWARD | 247,290 | $2.35 | $581.1K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | AWARD | 223,000 | $2.35 | $524.0K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | AWARD | 215,000 | $2.35 | $505.3K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | AWARD | 34,620 | $2.35 | $81.4K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | DISPOSED | 223,000 | $14.88 | $3.3M | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | DISPOSED | 34,620 | $6.23 | $215.7K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | DISPOSED | 215,000 | $4.20 | $903.0K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Jul 3, 2025 | DISPOSED | 247,290 | $5.30 | $1.3M | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | AWARD | 202,329 | $2.35 | $475.5K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | AWARD | 135,000 | $2.35 | $317.3K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | AWARD | 90,000 | $2.35 | $211.5K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | AWARD | 44,962 | $2.35 | $105.7K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | AWARD | 33,833 | $2.35 | $79.5K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | DISPOSED | 202,329 | $5.30 | $1.1M | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | DISPOSED | 33,833 | $6.23 | $210.8K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | DISPOSED | 135,000 | $4.20 | $567.0K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Jul 3, 2025 | DISPOSED | 90,000 | $14.88 | $1.3M | Form 4 |
| Manji Husseini | director | May 13, 2025 | AWARD | 15,287 | $2.37 | $36.2K | Form 4 |
| Cox Christopher Nixon | director | May 13, 2025 | AWARD | 15,287 | $2.37 | $36.2K | Form 4 |
| Dreyfus Andrew | director | May 13, 2025 | AWARD | 15,287 | $2.37 | $36.2K | Form 4 |
| York Gwill | director | May 13, 2025 | AWARD | 15,287 | $2.37 | $36.2K | Form 4 |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Feb 5, 2025 | AWARD | 125,000 | $4.20 | $525.0K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Feb 5, 2025 | AWARD | 135,000 | $4.20 | $567.0K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Feb 5, 2025 | AWARD | 76,000 | $4.20 | $319.2K | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Feb 5, 2025 | AWARD | 215,000 | $4.20 | $903.0K | Form 4 |
| York Gwill | director | Jan 2, 2025 | AWARD | 19,558 | $4.38 | $85.7K | Form 4 |
| Manji Husseini | director | Jan 2, 2025 | AWARD | 14,195 | $4.38 | $62.2K | Form 4 |
| Cox Christopher Nixon | director | Jan 2, 2025 | AWARD | 25,236 | $4.38 | $110.5K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 10, 2024 | BUY | 2,931 | $13.22 | $38.7K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 9, 2024 | BUY | 1,388 | $13.15 | $18.3K | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Jul 9, 2024 | BUY | 10,681 | $12.53 | $133.8K | Form 4 |
| Hanley Jr. Michael Conick | Chief Operating Officer | May 20, 2024 | AWARD | 188,000 | $12.40 | $2.3M | Form 4 |
| Hanley Jr. Michael Conick | Chief Operating Officer | May 20, 2024 | OTHER | 8,000 | $14.88 | $119.0K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Mar 28, 2024 | BUY | 4,550 | $16.56 | $75.3K | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Mar 28, 2024 | BUY | 1,600 | $15.80 | $25.3K | Form 4 |
| Radhakrishnan Maha | director | Mar 8, 2024 | AWARD | 30,574 | $13.76 | $420.7K | Form 4 |
| Radhakrishnan Maha | director | Mar 8, 2024 | AWARD | 1,590 | $13.76 | $21.9K | Form 4 |
| Radhakrishnan Maha | Mar 8, 2024 | OTHER | 0 | — | — | Form 4 | |
| Apeiron Investment Group Ltd. | other: See Remarks | Feb 6, 2024 | CONVERSION | 674,658 | — | — | Form 4 |
| Apeiron Investment Group Ltd. | other: See Remarks | Feb 6, 2024 | CONVERSION | 251,881 | — | — | Form 4 |
| Apeiron Investment Group Ltd. | other: See Remarks | Feb 6, 2024 | CONVERSION | 444,561 | — | — | Form 4 |
| Apeiron Investment Group Ltd. | other: See Remarks | Feb 6, 2024 | CONVERSION | 1,063,918 | — | — | Form 4 |
| Apeiron Investment Group Ltd. | other: See Remarks | Feb 6, 2024 | CONVERSION | 416,665 | — | — | Form 4 |
| Savitz Adam | CHIEF MEDICAL OFFICER | Mar 1, 2024 | AWARD | 73,000 | $14.88 | $1.1M | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Mar 1, 2024 | AWARD | 34,711 | — | — | Form 4 |
| Etkin Amit | director, officer: PRESIDENT AND CEO | Mar 1, 2024 | AWARD | 223,000 | $14.88 | $3.3M | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Mar 1, 2024 | AWARD | 90,000 | $14.88 | $1.3M | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Mar 1, 2024 | AWARD | 19,153 | — | — | Form 4 |
| Alpha Wave Global, LP | 10 percent owner | Feb 6, 2024 | BUY | 600,000 | $16.00 | $9.6M | Form 4 |
| Alpha Wave Global, LP | 10 percent owner | Feb 6, 2024 | CONVERSION | 1,144,762 | — | — | Form 4 |
| Alpha Wave Global, LP | 10 percent owner | Feb 6, 2024 | CONVERSION | 1,962,995 | — | — | Form 4 |
| Alpha Wave Global, LP | 10 percent owner | Feb 6, 2024 | CONVERSION | 1,962,995 | — | — | Form 4 |
| Alpha Wave Global, LP | 10 percent owner | Feb 6, 2024 | CONVERSION | 1,144,763 | — | — | Form 4 |